NDC product
Dextrose and Electrolyte No. 48
NDC 0338-0143 · Baxter Healthcare Company
Key facts
| Product NDC | 0338-0143 |
|---|---|
| Proprietary name | Dextrose and Electrolyte No. 48 |
| Nonproprietary name | Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride and Dextrose monohydrate |
| Substances | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, SODIUM CHLORIDE |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | Baxter Healthcare Company |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA017484 |
| Pharmacologic classes | Acidifying Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS] and 1 more |
| Marketing start | Feb 2, 1979 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: